Custom Antibody Market Overview:
The global custom antibody market is expected to exhibit USD 352 Million by 2030 at 9.80% CAGR during the forecast period 2023-2030. According to a new market intelligence report from Market Research Future (MRFR). The global custom antibody market research is primarily driven by the growing demand from the life sciences sector, which has been driven by the growing demand for cellular research. The report presents a comprehensive view of the global custom antibody market to the readers with the help of historical statistics illustrating the growth of the market through the review period along with the market’s current figures, to present reliable forecasts about the market’s movement over the forecast period from 2022 to 2030.
Custom antibodies are used in cellular research of all kinds, making them among the most popular products in the biotechnology industry today. Cellular research has taken on a vital role in the investigation into the origin and treatment of diseases such as cardiovascular diseases, infectious diseases, and cancer. This has driven the demand from the global custom antibody market and is likely to remain the major market driver over the forecast period. The growing incidence of pathogenic and contagious diseases in the world is likely to be a major driver for the market over the forecast period. The increasing role of genetics in cancer research is also likely to be a major driver for the global custom antibody market, as cancer research is likely to be one of the best funded arms of healthcare research over the forecast period.
Companies in the global custom antibody market have gone to great lengths to provide absolute customization, along with online support for data storage and project tracking, which has steadily driven the demand from the market. Genetic research has become more important than ever in the life sciences sector due to its effectiveness in treating diseases at the root cause. This is likely to be one of the major drivers for the global custom antibody market over the forecast period.
The global custom antibody market is segmented on the basis of service, source, type, research area, and end user.
On the basis of service, the global custom antibody market is segmented into antibody development, antibody fragmentation labeling, and antibody production purification. The antibody development segment is further divided into antibody characterization, antigen preparation, and immunization hybridoma production.
On the basis of source, the market has been classified as mice, rabbits, human beings, and others.
On the basis of type, the market has been segmented into monoclonal antibodies, polyclonal antibodies, recombinant antibodies, and others.
On the basis of research area, the market has been classified as oncology, infectious diseases, immunology, neurobiology, stem cells, cardiovascular diseases, and other research areas.
In terms of end users, the market has been classified as pharmaceutical biotechnology companies, hospitals and clinics, academic research institutes, and contract research organizations.
The global custom antibody market is likely to be dominated by the Americas and Europe segments over the forecast period due to the presence of a solid, well-equipped research arm for the healthcare sector in these regions. Global pharmaceutical industry leaders are situated mostly in the U.S. or Europe, leading to the two regions accruing a dominant share in the market. The growing healthcare expenditure in the U.S., the UK, Germany, and France is also likely to be a major driver for the custom antibody market over the forecast period. Both Americas and Europe account for more than a third of the global custom antibody market and are likely to retain their dominance over the forecast period due to the growing prospects of the medical research sector in the region and the growing private funding for the healthcare sector.
Leading global custom antibody market players include Thermo Fisher Scientific Inc., Abcam PLC, Bio-Rad Laboratories, Agilent Technology Inc., Rockland Immunochemicals Inc., Proteogenix, Innovagen AB, Promab Biotechnologies Inc., Biolegend Inc., Cell Signaling Technology Inc., Merck Group, and Genscript.
In January 2019, Abcam announced an expansion of their custom antibody catalog with the acquisition of Calico Biolabs.
About Market Research Future:
At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Consulting Services. MRFR team have supreme objective to provide the optimum quality market research and intelligence services to our clients.
Market Research Future (part of Wantstats Research and Media Private Limited),
99 Hudson Street, 5Th Floor,
New York, New York 10013
United States of America
+1 628 258 0071